Croda Showcases High-Purity Pharma Excipients at CPhI Worldwide 2017

October 16, 2017
Pharmaceutical Technology Editors

Croda is showcasing its portfolio of high-purity pharmaceutical excipients that can be used to maximize API performance.

Croda, a supplier of natural-based specialty chemicals, is showcasing its portfolio of high-purity pharmaceutical excipients that can be used to maximize API performance at CPhI Worldwide 2017. The company has manufacturing facilities around the globe.

Experts from Croda will be available to talk about the benefits of high-purity pharmaceutical ingredients for multiple drug administration routes, including the parenteral, ophthalmic, oral, and topical routes.

Visitor can visit Croda at CPhI to learn more about:

  • Improved API stability

  • Reduced cellular irritation

  • Increased API delivery

  • Accelerated speed to market

  • Reducing drug development times

  • Simplifying formulations

Source: Croda, Stand 102B11

Related Content:

CPhI News | PharmTech News